KR100243981B1 - 결정상태의 에토포사이드 4'-포스페이트 디에탄올레이트 - Google Patents

결정상태의 에토포사이드 4'-포스페이트 디에탄올레이트 Download PDF

Info

Publication number
KR100243981B1
KR100243981B1 KR1019920018032A KR920018032A KR100243981B1 KR 100243981 B1 KR100243981 B1 KR 100243981B1 KR 1019920018032 A KR1019920018032 A KR 1019920018032A KR 920018032 A KR920018032 A KR 920018032A KR 100243981 B1 KR100243981 B1 KR 100243981B1
Authority
KR
South Korea
Prior art keywords
etoposide
phosphate
diethanolate
solution
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1019920018032A
Other languages
English (en)
Korean (ko)
Other versions
KR930007968A (ko
Inventor
데니스파브로
Original Assignee
스티븐 비. 데이비스
브리스톨-마이어스스퀴브컴파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스티븐 비. 데이비스, 브리스톨-마이어스스퀴브컴파니 filed Critical 스티븐 비. 데이비스
Publication of KR930007968A publication Critical patent/KR930007968A/ko
Application granted granted Critical
Publication of KR100243981B1 publication Critical patent/KR100243981B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1019920018032A 1991-10-08 1992-10-01 결정상태의 에토포사이드 4'-포스페이트 디에탄올레이트 Expired - Lifetime KR100243981B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/773,056 US5648474A (en) 1991-10-08 1991-10-08 Crystalline etoposide 4'-phosphate diethanolate
US773056 1991-10-08

Publications (2)

Publication Number Publication Date
KR930007968A KR930007968A (ko) 1993-05-20
KR100243981B1 true KR100243981B1 (ko) 2000-02-01

Family

ID=25097069

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920018032A Expired - Lifetime KR100243981B1 (ko) 1991-10-08 1992-10-01 결정상태의 에토포사이드 4'-포스페이트 디에탄올레이트

Country Status (27)

Country Link
US (1) US5648474A (https=)
EP (1) EP0537555B1 (https=)
JP (1) JP3205816B2 (https=)
KR (1) KR100243981B1 (https=)
CN (1) CN1030610C (https=)
AT (1) ATE156832T1 (https=)
AU (1) AU650572B2 (https=)
CA (1) CA2079581C (https=)
CZ (1) CZ283735B6 (https=)
DE (1) DE69221573T2 (https=)
DK (1) DK0537555T3 (https=)
EG (1) EG20187A (https=)
ES (1) ES2109970T3 (https=)
FI (1) FI105034B (https=)
GR (1) GR3025176T3 (https=)
HU (2) HU213606B (https=)
IL (1) IL103262A (https=)
MX (1) MX9205777A (https=)
MY (1) MY108969A (https=)
NO (1) NO178342C (https=)
NZ (1) NZ244521A (https=)
PH (1) PH31666A (https=)
PL (1) PL168332B1 (https=)
RU (1) RU2042686C1 (https=)
SK (1) SK298692A3 (https=)
TW (1) TW239863B (https=)
ZA (1) ZA926903B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459248A (en) * 1993-11-04 1995-10-17 Bristol-Myers Squibb Company Process of preparing etoposide phosphate and etoposide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670578A (en) * 1983-08-29 1987-06-02 Merck & Co., Inc. Process for crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters
US4914222A (en) * 1983-08-29 1990-04-03 Merck & Co., Inc. Crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process
US4713246A (en) * 1984-03-19 1987-12-15 Bristol-Myers Company Etoposide oral dosage form
US4775751A (en) * 1985-06-03 1988-10-04 Eli Lilly & Company Process for cephalexin hydrochloride alcoholates
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US4904768A (en) * 1987-08-04 1990-02-27 Bristol-Myers Company Epipodophyllotoxin glucoside 4'-phosphate derivatives
DE68912721T2 (de) * 1988-11-16 1994-05-11 Nippon Kayaku Kk Kristallines Hydrochlorid von einer Etoposid-2-dimethylamino-Verbindung und Verfahren zur Herstellung davon.
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides

Also Published As

Publication number Publication date
SK278935B6 (sk) 1998-04-08
EP0537555B1 (en) 1997-08-13
ATE156832T1 (de) 1997-08-15
IL103262A0 (en) 1993-02-21
ES2109970T3 (es) 1998-02-01
CZ298692A3 (en) 1993-04-14
FI105034B (fi) 2000-05-31
HU9203119D0 (en) 1992-12-28
MY108969A (en) 1996-11-30
EG20187A (en) 1997-09-30
FI924359L (fi) 1993-04-09
AU2530192A (en) 1993-04-22
FI924359A0 (fi) 1992-09-29
NO178342C (no) 1996-03-06
PL296078A1 (en) 1993-04-19
NO923754L (no) 1993-04-13
DK0537555T3 (da) 1998-01-26
TW239863B (https=) 1995-02-01
NO178342B (no) 1995-11-27
JPH05194575A (ja) 1993-08-03
CA2079581A1 (en) 1993-04-09
US5648474A (en) 1997-07-15
CZ283735B6 (cs) 1998-06-17
ZA926903B (en) 1993-05-03
CN1030610C (zh) 1996-01-03
HU213606B (en) 1997-08-28
PL168332B1 (pl) 1996-02-29
AU650572B2 (en) 1994-06-23
DE69221573D1 (de) 1997-09-18
JP3205816B2 (ja) 2001-09-04
CN1071432A (zh) 1993-04-28
DE69221573T2 (de) 1998-02-26
RU2042686C1 (ru) 1995-08-27
SK298692A3 (en) 1998-04-08
IL103262A (en) 1997-06-10
HU211672A9 (en) 1995-12-28
NO923754D0 (no) 1992-09-28
NZ244521A (en) 1994-02-25
MX9205777A (es) 1993-04-01
GR3025176T3 (en) 1998-02-27
CA2079581C (en) 2002-11-12
EP0537555A1 (en) 1993-04-21
PH31666A (en) 1999-01-12
HUT62309A (en) 1993-04-28
KR930007968A (ko) 1993-05-20

Similar Documents

Publication Publication Date Title
AU615509B2 (en) Temperature stable crystalline salts of 7-(alpha-(2- aminothiazol-4-yl)-alpha-(Z)-methoxyiminoacetamidol)-3- ((1-methyl-1-pyrrolidino)methyl)-3-cephem-4-carboxylate
KR100403256B1 (ko) 결정성n-아세틸뉴라민산유도체및그제조방법
RU2648990C1 (ru) Кристаллы лобаплатина, способы получения и применения в фармацевтике
IE862078L (en) Cephalosporin salts
KR100243981B1 (ko) 결정상태의 에토포사이드 4'-포스페이트 디에탄올레이트
KR910008799B1 (ko) 에피포도필로톡신 배당체의 4'-아실 유도체
KR960010947B1 (ko) 2'-데옥시-2'메틸리덴시티딘 이수화물 이의 제조방법 및 조성물
EP0587121B1 (en) Crystalline dihydrate of a cephalosporin dihydrochloride salt and injectable compositions thereof
CN108997430A (zh) 一种二丁酰环磷腺苷钙盐的晶体
CN104884128B (zh) 力格赛狄盐及其晶型、它们的制备方法和用途
US4558053A (en) Naphthalene-1,5-disulfonate salts of dimeric indole-dihydroindole alkaloids
US5401842A (en) Injectable compositions of a cephalosporin dihydrate salt
EP0548834B1 (en) Stable hexahydrate of etoposide 4'-phosphate disodium salt
CN116496247A (zh) 6-(1-丙烯酰基哌啶-4-基)-2-(4-苯氧基苯基)尼克酰胺的晶型
CN110790791A (zh) 一种洛铂的无水合物晶体、制备方法及药物应用
EP4273116A1 (en) Crystal form and amorphous form of honokiol, and preparation method therefor
EP0400889B1 (en) Crystalline deoxyspergualin and process for its preparation
KR20230092805A (ko) (2R, 3S)-2-(3-(4,5-디클로로-1H-벤조[d]이미다졸-1-일)프로필)피페리딘-3-올의 신규한 산부가염 및 결정형
KR20250013212A (ko) N-(벤조일기)-페닐알라닌 파생 화합물의 결정체 및 그 약물 조성물, 제조 방법과 용도
KR940008595B1 (ko) I-β-D-아라비노푸라노실시토신-5'-스테아릴포스페이트 모노나트륨염 모노하이드레이트 및 이 모노하이드레이트를 함유하는 약제 조성물
JPS6351385A (ja) 新規なジアミノピリミド〔4,5−d〕ピリミジングリコシドおよびグリコチド
HU196808B (en) Process for producing crystalline monohydrate of /5r,6s/-2-amino-methyl-6-//1r/-1-hydroxy-ethyl/-2-peneme-3-carboxylic acid
CN104045613A (zh) (1s)-1-[4-氯-3-(4-乙氧基苄基)苯基]-1,6-二脱氧-d-葡萄糖和l-脯氨酸的共结晶i及其制备方法和应用

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19921001

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19970905

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19921001

Comment text: Patent Application

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19991029

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19991119

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19991120

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20021107

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20031106

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20041109

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20051111

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20061110

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20071106

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20081110

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20091110

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20101118

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20111101

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20111101

Start annual number: 13

End annual number: 13

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20130709

Termination category: Expiration of duration